Current through Register Vol. 47, No. 17, September 10, 2024
Basis and Purpose - 3205
The statutory authority for this rule includes but is not
limited to sections
44-50-202(1)(b),
44-50-203(1)(j),
44-50-203(1)(b),
44-50-203(2)(g),
44-50-203(2)(i),
44-50-203(2)(k),
and 44-50-203(2)(p),
C.R.S. The purpose of this rule is to establish minimum requirements for a
recall plan and the process by which the Division or a Natural Medicine
Business initiates, performs, and terminates a recall.
A.
Applicability.
This Rule 3205 applies to all Natural Medicine Business Licensees. Owner
Licensees are responsible for the recall plan and the necessary steps for a
recall in accordance with this Rule. The recall plan may designate additional
Natural Medicine Handler Licensees as points of contact in the event of a
recall.
B.
Initiating a
Recall. A Natural Medicine Business may initiate a recall at any
time, or a recall may be initiated at the Division's request. Natural Medicine
Businesses must comply with the requirements of this Rule 3205.
1.
Division Request for
Recall.
a. If the Division
requests a Natural Medicine Business initiate a recall pursuant to this Rule,
the Division's correspondence, which may be electronic, must include the
reasons for the recall request and any other information necessary for the
Natural Medicine Business to initiate the recall.
b. A Division request for recall does not
require the Natural Medicine Business to initiate a recall. However, if the
Division has reasonable grounds to believe a Licensee's Regulated Natural
Medicine or Regulated Natural Medicine Product is contaminated or otherwise
presents a risk to public safety, the Division may require a Natural Medicine
Business to quarantine or embargo the affected inventory.
2.
Voluntary Recall.
a. A Natural Medicine Business may
voluntarily initiate a recall.
b.
If a Natural Medicine Business elects to initiate a recall, the Licensee must
notify the Division at least 24 hours prior to notifying other Licensees,
Facilitators, Participants, or other interested or affected persons in order to
facilitate coordination between the Licensee and the
Division.
C.
Recall Plan Required. Natural Medicine Cultivation
Facilities and Natural Medicine Products Manufacturers must have a written
recall plan. A recall plan shall include, but is not limited to, the following:
1.
Evaluation of a Complaint or
Condition. Natural Medicine Businesses must maintain a record of
all complaints it receives regarding the quality of Regulated Natural Medicine
and Regulated Natural Medicine Product that has any potential negative impact
to health or an adverse reaction in accordance with Rule 3015. If an initial
assessment indicates a recall may be necessary, the Natural Medicine Business
shall:
a. Determine the hazard and evaluate
the safety concerns with the product;
b. Undertake necessary product quarantine
measures for any affected Regulated Natural Medicine and Regulated Natural
Medicine Product; and
c. Determine
the appropriate product removal strategy considering the potential adverse
reactions and amount of product transferred to other Licensees and
Participants.
2.
Identification of Affected Regulated Natural Medicine and Regulated
Natural Medicine Product. A recall plan must establish a process
for identifying affected Regulated Natural Medicine and/or Regulated Natural
Medicine Product, which shall include the following:
a.
Distribution
List. When identifying Regulated Natural Medicine and/or Regulated
Natural Medicine Product subject to a recall, the Licensee shall create a
distribution list that includes the following information:
i. The name, license number, and address of
the Natural Medicine Business(es) that received the Regulated Natural Medicine
and/or Regulated Natural Medicine Product subject to the recall;
ii. Ship or transfer date(s) for the
Regulated Natural Medicine and/or Regulated Natural Medicine Product subject to
the recall; and
iii. Business
contact information for each Natural Medicine Business that received Regulated
Natural Medicine and Regulated Natural Medicine Product subject to the recall,
including names and telephone numbers.
b.
Product
Information. When identifying Regulated Natural Medicine and/or
Regulated Natural Medicine Product subject to a recall, the Licensee shall
document the following product information:
i. Product description;
ii. Net contents;
iii. Harvest Lot and/or Production Lot
number;
iv. The license number(s)
for the Natural Medicine Business(es) that cultivated or manufactured the
Regulated Natural Medicine and/or Regulated Natural Medicine Product subject to
the recall; and
v. To the extent
known after reasonable diligence to collect information, the recall plan must
also include the following additional product information: the amount of
affected Regulated Natural Medicine and Regulated Natural Medicine Product
returned to the Natural Medicine Cultivation or Natural Medicine Product
Manufacturer in response to the recall.
3.
Notifications.
a. A Licensee initiating a recall pursuant to
this Rule shall issue a recall notice to all Natural Medicine Businesses
identified on the Licensee's distribution list.
b. No later than 48 hours after issuing a
recall notice to all Natural Medicine Businesses on the Licensee's distribution
list, the Licensee shall also:
i. Notify the
Division and the Department of Public Health & Environment that the recall
has been initiated; and
ii. Post an
alert on the Licensee's website, social media, or other method of notifying
Participants and Facilitators.
c.
Recall Notice. A
recall notice issued by a Natural Medicine Business pursuant to this Rule shall
include at least the following information:
i.
The reason for recall and related hazards, if any. If the Regulated Natural
Medicine and/or Regulated Natural Medicine Product is being removed for quality
rather than health reasons, the notice may state that the Regulated Natural
Medicine and Regulated Natural Medicine Product does not meet internal company
specifications and is being removed from distribution;
ii. Natural Medicine Businesses that received
the Regulated Natural Medicine and/or Regulated Natural Medicine
Product;
iii. The License number(s)
and name(s), including trade names or "doing business as" names, of the Natural
Medicine Business(es) that cultivated or manufactured the Regulated Natural
Medicine and/or Regulated Natural Medicine Product subject to the
recall;
iv. Product description(s)
for Regulated Natural Medicine and/or Regulated Natural Medicine Product
subject to the recall;
v.
Expiration date(s) for the Regulated Natural Medicine and/or Regulated Natural
Medicine Product subject to the recall, if applicable;
vi. Ship or transfer date(s) for the
Regulated Natural Medicine and/or Regulated Natural Medicine Product subject to
the recall; and
vii. Instructions
regarding the disposition of Regulated Natural Medicine and/or Regulated
Natural Medicine Product subject to the recall.
4.
Removal of Affected Regulated
Natural Medicine and Regulated Natural Medicine Product.
a.
Removal. A
Natural Medicine Business shall make all reasonable efforts to remove the
affected Regulated Natural Medicine and/or Regulated Natural Medicine Product
from licensed Facilities. Affected Regulated Natural Medicine and Regulated
Natural Medicine Product that is either still in control of the originating
Licensee or located at another Licensed Premises shall be secured, segregated,
clearly labeled "Not for Distribution," and separated from any other Regulated
Natural Medicine and Regulated Natural Medicine Product.
b.
Disposal.
Regulated Natural Medicine and Regulated Natural Medicine Product subject to a
recall under this Rule shall be disposed of in accordance with Rule
3120.
c.
Recall
Effectiveness. A Natural Medicine Business initiating a recall
pursuant to this Rule is responsible for determining whether the recall is
effective. The Licensee shall complete recall effectiveness checks to verify
that all receiving Licensees have been notified and have taken the appropriate
action.
i. Effectiveness checks shall
determine:
A. If the receiving Licensee(s)
received the recall notification;
B. If the recalled Regulated Natural Medicine
and Regulated Natural Medicine Product was handled as instructed in the recall
notification; and
C. If the
Regulated Natural Medicine and Regulated Natural Medicine Product was further
dispensed by the receiving Licensee before receipt of the recall notification,
and if so, were additional Licensees, Participants, and Facilitators
notified.
ii. If the
Licensee accounts for 100 percent of the affected Regulated Natural Medicine
and Regulated Natural Medicine Product, then no effectiveness checks are
required.
5.
Annual Audit of Recall Plan. The Natural Medicine
Business must annually audit their recall plan to determine if any changes in
the operation of their business would require an update to the
plan.
D.
Termination of Recall.
1. A Natural Medicine Business initiating a
recall pursuant to this Rule may terminate a recall when the Licensee
determines that reasonable efforts have been made to remove or correct the
affected Regulated Natural Medicine and/or Regulated Natural Medicine Product
in accordance with the recall plan, and when it is reasonable to assume that
the Regulated Natural Medicine and/or Regulated Natural Medicine Product
subject to the recall has been removed and properly disposed of, or correction
has been made commensurate with the degree of the hazard of the recalled
Regulated Natural Medicine and/or Regulated Natural Medicine Product.
2. Upon termination of the recall, the
Natural Medicine Business shall provide notice to the Division with a recall
status report and a description of the disposition of the recalled Regulated
Natural Medicine and/or Regulated Natural Medicine Product. The recall status
report shall contain the following information:
a. Number of receiving Licensees notified of
the recall, the date, and method of notification;
b. Number of receiving Licensees who
responded to the recall notice and both the quantity of affected Regulated
Natural Medicine and/or Regulated Natural Medicine Product in the possession of
the Licensee at the time of the response, and quantity of affected product
returned or corrected;
c. Number
and results of the effectiveness checks that were made; and d. Approximate time
that was required to complete the recall.